$VRX News Not all pharmaceuticals are created eq
Post# of 72749
Posted On: 01/10/2014 1:05:18 PM
$VRX News
Not all pharmaceuticals are created equal 12:40 p.m. Dec. 26, 2013 - The Trading Deck
2 leading growth stocks setting up for a move 1:29 p.m. Dec. 24, 2013 - The Trading Deck
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
S&P 500 hesitates at major resistance 12:31 p.m. Nov. 12, 2013 - Michael Ashbaugh
S&P 500 hesitates at major resistance 12:16 p.m. Nov. 12, 2013 - Michael Ashbaugh
Valeant swings to loss as costs overshadow revenue 6:11 a.m. Oct. 31, 2013 - MarketWatch.com
Valeant to pay Anacor $142.5 mln to settle dispute 8:42 a.m. Oct. 28, 2013 - MarketWatch.com
Julian Robertson's top stock picks 1:47 p.m. Aug. 15, 2013 - Insider Monkey
Insiders are busy buying these stocks 2:38 p.m. Aug. 14, 2013 - Insider Monkey
Private-equity firms take the money and run 5:15 a.m. Aug. 9, 2013 - Howard Gold
Valeant swings to Q2 profit as revenue rises 34% 9:39 a.m. Aug. 7, 2013 - MarketWatch.com
Julian Robertson's long-term stock picks 7:09 a.m. July 22, 2013 - Insider Monkey
Hospitals, drug firms, device makers win with Obamacare, analyst says 7:43 a.m. July 17, 2013 - Russ Britt
S&P back for another crack at major resistance 11:08 a.m. July 2, 2013 - Michael Ashbaugh
S&P back for another crack at major resistance 10:48 a.m. July 2, 2013 - Michael Ashbaugh
Valeant raises $2 billion in stock offering 3:06 a.m. June 19, 2013 - MarketWatch.com
What are insiders buying these days? 11:47 a.m. June 18, 2013 - Insider Monkey
Charting a resilient bull market 10:56 a.m. June 11, 2013 - Michael Ashbaugh
Charting a resilient bull market 10:50 a.m. June 11, 2013 - Michael Ashbaugh
Lone Pine Capital's new stock picks 10:43 a.m. May 31, 2013 - Insider Monkey
5 Health Care Stocks Dragging The Sector Down 12:02 p.m. Today - TheStreet.com
Are Generic Drug Stocks The Cure For A Hung-Over Health Care Market? 12:46 a.m. Today - Seeking Alpha
Valeant Pharmaceuticals International Inc (VRX): Today's Featured Health Care Winner 5:00 p.m. Jan. 9, 2014 - TheStreet.com
Buy The Rip: Valeant Pharmaceuticals 5:31 a.m. Jan. 9, 2014 - Seeking Alpha
FDA lists four new drugs mentioned in Paragraph IV ANDAs 3:59 p.m. Jan. 8, 2014 - Seeking Alpha
Sell-side reacts to Valeant chief's ambitious goals 2:34 p.m. Jan. 8, 2014 - Seeking Alpha
Valeant Pharmaceuticals International (VRX) Hits New Lifetime High 9:46 a.m. Jan. 8, 2014 - TheStreet.com
UPDATE: Morgan Stanley Upgrades Valeant Pharmaceuticals On Durability of Pricing Growth 7:29 a.m. Jan. 8, 2014 - benzinga.com
Pharmacyclics, Valeant, Celgene Up On Bullish News 5:45 p.m. Jan. 7, 2014 - Investors Business Daily
Valeant aims to be top-five pharmaceutical company by 2016 1:12 p.m. Jan. 7, 2014 - Seeking Alpha
Valeant 2014 guidance in line with the Street 8:54 a.m. Jan. 7, 2014 - Seeking Alpha
Top 20 TSX Short Positions Dec. 31 8:39 a.m. Jan. 7, 2014 - Seeking Alpha
22 Biotech Stock Predictions for 2014 7:58 a.m. Jan. 6, 2014 - TheStreet.com
Valeant Is Having a Healthy Run 6:30 a.m. Jan. 3, 2014 - TheStreet.com
Pfizer Is Old News, But Valeant Isn't 3:52 a.m. Jan. 3, 2014 - Seeking Alpha
Prescription Drug Stocks Near Breakout Points 4:39 p.m. Jan. 2, 2014 - Investors Business Daily
Ambarella, Jazz Among Stocks Outpacing Record Market 7:02 a.m. Dec. 31, 2013 - Investors Business Daily
Jazz, Valeant Join Drug Makers' Q4 Merger Rush 5:39 p.m. Dec. 30, 2013 - Investors Business Daily
Health Care Is The Leading Sector In the Big Cap 20 5:04 p.m. Dec. 30, 2013 - Investors Business Daily
Smoothing Out the Wrinkles 3:56 a.m. Dec. 28, 2013 - Barrons.com
Quick Market Round-up before the Bell: Delcath Systems, Valeant Pharma Intl., BioMarin Pharma, and Insmed 8:00 a.m. Jan. 9, 2014 - PR Newswire
Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan 8:00 a.m. Jan. 7, 2014 - PR Newswire
Presentation of Clinical Study Data, Prestigious Accolades, and Acquisitions - Research Report on Celgene, UnitedHealth, AstraZeneca, Mylan, and Valeant 8:00 a.m. Dec. 25, 2013 - PR Newswire
Valeant Pharmaceuticals To Present At Industry Conferences 8:00 a.m. Dec. 20, 2013 - PR Newswire
Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors 8:00 a.m. Dec. 17, 2013 - PR Newswire
Clinical Study Data Presentation, Product Launches, Technology Deployments, and Stock Price Movements - Research Report on Celgene, Mylan, Valeant, Health Management, and CareFusion 8:00 a.m. Dec. 17, 2013 - PR Newswire
Acquisition of Solta Medical, Inc. by Valeant Pharmaceuticals International, Inc. May Not Be in Shareholders' Best Interests 7:44 p.m. Dec. 16, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Solta Medical, Inc. Stockholders 4:54 p.m. Dec. 16, 2013 - BusinessWire
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Solta Medical, Inc. 2:00 p.m. Dec. 16, 2013 - BusinessWire
SOLTA MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 11:17 a.m. Dec. 16, 2013 - BusinessWire
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash 8:00 a.m. Dec. 16, 2013 - PR Newswire
Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance 6:35 p.m. Dec. 13, 2013 - PR Newswire
RBCC and Therakine Initiate Phase II of Drug Delivery Development 5:00 a.m. Dec. 12, 2013 - BusinessWire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's 8:00 a.m. Dec. 6, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Dec. 2, 2013 - PR Newswire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
Valeant Pharmaceuticals Announces New Management Appointment 8:00 a.m. Nov. 25, 2013 - PR Newswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 8:00 a.m. Nov. 22, 2013 - PR Newswire
Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Nov. 15, 2013 - PR Newswire
Not all pharmaceuticals are created equal 12:40 p.m. Dec. 26, 2013 - The Trading Deck
2 leading growth stocks setting up for a move 1:29 p.m. Dec. 24, 2013 - The Trading Deck
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
S&P 500 hesitates at major resistance 12:31 p.m. Nov. 12, 2013 - Michael Ashbaugh
S&P 500 hesitates at major resistance 12:16 p.m. Nov. 12, 2013 - Michael Ashbaugh
Valeant swings to loss as costs overshadow revenue 6:11 a.m. Oct. 31, 2013 - MarketWatch.com
Valeant to pay Anacor $142.5 mln to settle dispute 8:42 a.m. Oct. 28, 2013 - MarketWatch.com
Julian Robertson's top stock picks 1:47 p.m. Aug. 15, 2013 - Insider Monkey
Insiders are busy buying these stocks 2:38 p.m. Aug. 14, 2013 - Insider Monkey
Private-equity firms take the money and run 5:15 a.m. Aug. 9, 2013 - Howard Gold
Valeant swings to Q2 profit as revenue rises 34% 9:39 a.m. Aug. 7, 2013 - MarketWatch.com
Julian Robertson's long-term stock picks 7:09 a.m. July 22, 2013 - Insider Monkey
Hospitals, drug firms, device makers win with Obamacare, analyst says 7:43 a.m. July 17, 2013 - Russ Britt
S&P back for another crack at major resistance 11:08 a.m. July 2, 2013 - Michael Ashbaugh
S&P back for another crack at major resistance 10:48 a.m. July 2, 2013 - Michael Ashbaugh
Valeant raises $2 billion in stock offering 3:06 a.m. June 19, 2013 - MarketWatch.com
What are insiders buying these days? 11:47 a.m. June 18, 2013 - Insider Monkey
Charting a resilient bull market 10:56 a.m. June 11, 2013 - Michael Ashbaugh
Charting a resilient bull market 10:50 a.m. June 11, 2013 - Michael Ashbaugh
Lone Pine Capital's new stock picks 10:43 a.m. May 31, 2013 - Insider Monkey
5 Health Care Stocks Dragging The Sector Down 12:02 p.m. Today - TheStreet.com
Are Generic Drug Stocks The Cure For A Hung-Over Health Care Market? 12:46 a.m. Today - Seeking Alpha
Valeant Pharmaceuticals International Inc (VRX): Today's Featured Health Care Winner 5:00 p.m. Jan. 9, 2014 - TheStreet.com
Buy The Rip: Valeant Pharmaceuticals 5:31 a.m. Jan. 9, 2014 - Seeking Alpha
FDA lists four new drugs mentioned in Paragraph IV ANDAs 3:59 p.m. Jan. 8, 2014 - Seeking Alpha
Sell-side reacts to Valeant chief's ambitious goals 2:34 p.m. Jan. 8, 2014 - Seeking Alpha
Valeant Pharmaceuticals International (VRX) Hits New Lifetime High 9:46 a.m. Jan. 8, 2014 - TheStreet.com
UPDATE: Morgan Stanley Upgrades Valeant Pharmaceuticals On Durability of Pricing Growth 7:29 a.m. Jan. 8, 2014 - benzinga.com
Pharmacyclics, Valeant, Celgene Up On Bullish News 5:45 p.m. Jan. 7, 2014 - Investors Business Daily
Valeant aims to be top-five pharmaceutical company by 2016 1:12 p.m. Jan. 7, 2014 - Seeking Alpha
Valeant 2014 guidance in line with the Street 8:54 a.m. Jan. 7, 2014 - Seeking Alpha
Top 20 TSX Short Positions Dec. 31 8:39 a.m. Jan. 7, 2014 - Seeking Alpha
22 Biotech Stock Predictions for 2014 7:58 a.m. Jan. 6, 2014 - TheStreet.com
Valeant Is Having a Healthy Run 6:30 a.m. Jan. 3, 2014 - TheStreet.com
Pfizer Is Old News, But Valeant Isn't 3:52 a.m. Jan. 3, 2014 - Seeking Alpha
Prescription Drug Stocks Near Breakout Points 4:39 p.m. Jan. 2, 2014 - Investors Business Daily
Ambarella, Jazz Among Stocks Outpacing Record Market 7:02 a.m. Dec. 31, 2013 - Investors Business Daily
Jazz, Valeant Join Drug Makers' Q4 Merger Rush 5:39 p.m. Dec. 30, 2013 - Investors Business Daily
Health Care Is The Leading Sector In the Big Cap 20 5:04 p.m. Dec. 30, 2013 - Investors Business Daily
Smoothing Out the Wrinkles 3:56 a.m. Dec. 28, 2013 - Barrons.com
Quick Market Round-up before the Bell: Delcath Systems, Valeant Pharma Intl., BioMarin Pharma, and Insmed 8:00 a.m. Jan. 9, 2014 - PR Newswire
Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan 8:00 a.m. Jan. 7, 2014 - PR Newswire
Presentation of Clinical Study Data, Prestigious Accolades, and Acquisitions - Research Report on Celgene, UnitedHealth, AstraZeneca, Mylan, and Valeant 8:00 a.m. Dec. 25, 2013 - PR Newswire
Valeant Pharmaceuticals To Present At Industry Conferences 8:00 a.m. Dec. 20, 2013 - PR Newswire
Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors 8:00 a.m. Dec. 17, 2013 - PR Newswire
Clinical Study Data Presentation, Product Launches, Technology Deployments, and Stock Price Movements - Research Report on Celgene, Mylan, Valeant, Health Management, and CareFusion 8:00 a.m. Dec. 17, 2013 - PR Newswire
Acquisition of Solta Medical, Inc. by Valeant Pharmaceuticals International, Inc. May Not Be in Shareholders' Best Interests 7:44 p.m. Dec. 16, 2013 - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Solta Medical, Inc. Stockholders 4:54 p.m. Dec. 16, 2013 - BusinessWire
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Solta Medical, Inc. 2:00 p.m. Dec. 16, 2013 - BusinessWire
SOLTA MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 11:17 a.m. Dec. 16, 2013 - BusinessWire
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash 8:00 a.m. Dec. 16, 2013 - PR Newswire
Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance 6:35 p.m. Dec. 13, 2013 - PR Newswire
RBCC and Therakine Initiate Phase II of Drug Delivery Development 5:00 a.m. Dec. 12, 2013 - BusinessWire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's 8:00 a.m. Dec. 6, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Dec. 2, 2013 - PR Newswire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
Valeant Pharmaceuticals Announces New Management Appointment 8:00 a.m. Nov. 25, 2013 - PR Newswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 8:00 a.m. Nov. 22, 2013 - PR Newswire
Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Nov. 15, 2013 - PR Newswire
(0)
(0)